Da Fonseca, Leonardo G.; Woerns, Marcus-A
The alpha and beta eta in phase II trials hepatocellular carcinoma - A tale of more than radiological response?LIVER INTERNATIONAL. Bd. 39. H. 8. 2019 S. 1391-1393
Le Pen, C.; Fricke, F. U.; Newsome, P. et al.
THE BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE EU5 COUNTRIESVALUE IN HEALTH. Bd. 22. 2019 S. S621-S621
Marquardt, Jens U.; Saborowski, Anna; Czauderna, Carolin et al.
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and ImmunotherapiesTARGETED ONCOLOGY. Bd. 14. H. 2. 2019 S. 115-123
Newsome, Philip N.; Schattenberg, Joern; Serfaty, Lawrence et al.
THE ECONOMIC COST AND HEALTH BURDEN OF NON ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIESHEPATOLOGY. Bd. 70. 2019 S. 249A-251A
Zahn, Daniela; Gomille, Lara K.; Grammes, Jennifer et al.
The Effects of Self-Control on Glucose Utilization in a Hyperinsulinemic Euglycemic Glucose ClampEUROPEAN JOURNAL OF HEALTH PSYCHOLOGY. Bd. 26. H. 4. 2019 S. 111-119
Gulati, Shraddha; Patel, Mehul; Emmanuel, Andrew et al.
The future of endoscopy: Advances in endoscopic image innovationsDIGESTIVE ENDOSCOPY. 2019
Schmidtke, Lisa; Schrick, Katharina; Saurin, Sabrina et al.
The KH-type splicing regulatory protein (KSRP) regulates type III interferon expression post-transcriptionallyBIOCHEMICAL JOURNAL. Bd. 476. 2019 S. 333-352
Baechler, S. A.; Factor, V. M.; Dalla Rosa, I et al.
The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesisNATURE COMMUNICATIONS. Bd. 10. 2019
Nagel, Michael; Schattenberg, Joern
The non-alcoholic Fatty Liver Disease (NAFLD) as an inflammatory Systemic Disease A Challenge in the coming YearsGASTROENTEROLOGE. Bd. 14. H. 2. 2019 S. 149-150
Huang, Jonathan C.; Invernizzi, Pietro; Dalekos, George N. et al.
THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITISHEPATOLOGY. Bd. 70. 2019 S. 777A-779A